Helen of Troy Limited

NASDAQ:HELE

Household & Personal Products

Consumer Defensive
$37.05 +1.76%

+$0.47 today

Market cap
$866.62M
Beta
1.33
P/E (TTM)
-0.7
EPS (TTM)
-$39.08
52W Low $13.85High $33.73

Volume 0.29M

Average 0.65M

HELE Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Helen of Troy LimitedNASDAQ: HELE

Research & Development · Q4 FY2026 · quarter ended Feb 2026

Research & development remains negative

Q4 FY2026 research & development was $0, compared with $53.9M a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +4.1% a year.

Context

  • Research & development amounted to 3.0% of revenue in FY2026, up 0.2 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$0— QoQ
Last fiscal yearFeb 2026
$54M+0.2% YoY
LTMFeb 2026
$0-100.0% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+0.2%——
3-year CAGR+4.1%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
54M USD
Year-over-year change
+0.2%
4-year CAGR
+0.0%

Research & Development vs competitors

How HELE compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -100.0% is the 3rd highest of 4, against a peer median of -0.8%.
  • Research & development amounts to 0.0% of revenue for HELE, versus a peer median of 0.0%.
HELE Competitors
Research & Development for HELE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KVUEKenvue Inc.LTM Sep 2026$180M USD——1.2%
CLXThe Clorox CompanyLTM Sep 2026$117M USD-0.8%-5.6%1.6%
EPCEdgewell Personal Care CompanyLTM Mar 2026$58.5M USD-0.3%+1.2%2.8%
HELEHelen of Troy LimitedLTM Feb 2026$0 USD-100.0%+4.1%0.0%
PGThe Procter & Gamble CompanyLTM Sep 2026$0 USD——0.0%
ULUnilever PLCFY2025€0 EUR——0.0%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$0 USD——0.0%
REYNReynolds Consumer Products Inc.LTM Jun 2026$0 USD——0.0%
NWLNewell Brands Inc.LTM Jun 2026$0 USD-100.0%—0.0%
HBBHamilton Beach Brands Holding CompanyLTM Mar 2026$0 USD——0.0%
LCUTLifetime Brands, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding HELE) —-0.8%-2.2%0.0%

Competitors are the stored peer set for HELE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Feb 2022
FY2023
Feb 2023
FY2024
Feb 2024
FY2025
Feb 2025
FY2026
Feb 2026
Revenue2.22B2.07B2.01B1.91B1.79B
Cost of Revenue1.27B1.17B1.06B993.26M970.6M
Gross Profit953.19M899.35M948.66M914.41M815.69M
Gross Margin42.9%43.4%47.3%47.9%45.7%
Research & Development54M47.8M56.5M53.9M54M
Selling, General & Admin611.03M595.9M621.74M622.65M708.91M
Operating Expenses680.64M687.56M688.07M771.66M708.91M
Depreciation & Amortization35.83M44.68M51.5M55.05M53.3M
EBITDA310.88M286.94M301.32M268.61M(727.8M)
EBITDA Margin14.0%13.8%15.0%14.1%-40.7%
Operating Income272.55M211.79M260.59M142.75M106.79M
Operating Margin12.3%10.2%13.0%7.5%6.0%
Interest Income00000
Interest Expense12.84M40.75M53.07M51.92M57.74M
Other Income / Expenses(12.58M)(40.5M)(51.55M)(51.08M)(945.62M)
Income Before Tax259.97M171.29M209.04M91.66M(838.84M)
Pre-Tax Margin11.7%8.3%10.4%4.8%-47.0%
Income Tax Expense36.2M28.02M40.45M(32.09M)60.14M
Net Income223.76M143.27M168.59M123.75M(898.98M)
Net Margin10.1%6.9%8.4%6.5%-50.3%
EPS (Basic)9.275.987.065.38(39.08)
EPS (Diluted)9.175.957.035.37(39.08)
Weighted Avg Shares24.4M24.08M23.98M23.04M23M
Weighted Avg Shares (Diluted)24.41M24.09M23.97M23.07M23M

Helen of Troy Limited

NASDAQ:HELE

Intrinsic Alpha fair value

Locked

Current Price

$37.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.